We are live on ! Find out more
CLRBW

Cellectar Biosciences, Inc.
CLRBW

Delisted

CLRBW was delisted on the 20th of August, 2019.

Back to rankings

4 hedge funds and large institutions have $6K invested in Cellectar Biosciences, Inc. in 2018 Q1 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

20% more capital invested

Capital invested by funds: $5K → $6K (+$1K)

0% more funds holding

Funds holding: 4 → 4 (0)

Holders
4
Holders Change
–
Holders Change %
0%
% of All Funds
0.09%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter

CLRBW Hedge Fund Activity: Q1 2018 in Review

4 of the 4,373 institutional investors tracked by Wall St. Rank reported a position in Cellectar Biosciences, Inc. (CLRBW) for Q1 2018, worth a combined $6K — up 20% from $5K a quarter earlier.

Fund positioning in CLRBW was balanced in Q1 2018: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 0 trimmed.

  • 4 institutional investors held Cellectar Biosciences, Inc. (CLRBW) as of Q1 2018, unchanged from Q4 2017.
  • Funds reported $6K of Cellectar Biosciences, Inc. stock for Q1 2018, up 20% quarter-over-quarter.
  • 0 funds opened new Cellectar Biosciences, Inc. positions in Q1 2018 and 0 closed out.

Based on aggregated 13F filings for Q1 2018.